FDA panel rejects Sanofi-Aventis weight loss drug
June 13 2007
An FDA advisory panel today unanimously rejected Sanofi-Aventis weight-loss drug rimonabant after hearing testimony that the drug increases the risk ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.